| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | EP0880507B1 Quinazoline derivatives as antitumor agents |
| 04/13/2005 | CN1606547A 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196683C Amino-compound |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878717 HIV replication inhibiting pyrimidines |
| 04/12/2005 | US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878697 Containing one or more phosphorus-containing moieties; treating bone disorders |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030782A2 Carbene ligands and their use |
| 04/07/2005 | WO2005030758A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030734A1 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (ghs-r) antagonists |
| 04/07/2005 | WO2005030217A1 Quinazoline potassium channel inhibitors |
| 04/07/2005 | WO2005030216A1 5-arylpyrimidines as anticancer agents |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004066905B1 Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075357 5-arylpyrimidines as anticancer agents |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075353 Quinazolines and therapeutic use thereof |
| 04/07/2005 | US20050075352 3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
| 04/07/2005 | US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage |
| 04/07/2005 | US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2744997A1 C-met modulators and method of use |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | CA2539252A1 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 04/07/2005 | CA2539235A1 5-arylpyrimidines as anticancer agents |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1235813B1 Hydroxamic acid derivatives |
| 04/06/2005 | EP1218357B1 Quinazoline derivatives |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195742C Process to prepare sulfonamides |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/06/2005 | CN1195732C Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof |
| 04/06/2005 | CN1195521C Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 03/31/2005 | WO2005028450A1 Polymorphic forms of a known antihyperlipemic agent |
| 03/31/2005 | WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/31/2005 | WO2004084824A3 Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 03/31/2005 | WO2004008837A3 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
| 03/31/2005 | US20050070712 Pyrimidine derivatives as ghrelin receptor modulators |
| 03/31/2005 | US20050070706 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/31/2005 | US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 03/31/2005 | US20050070555 Aroyl pyridinones |
| 03/31/2005 | US20050070535 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 03/31/2005 | US20050070532 Peroxisome proliferator activated receptors (PPARS); for inhibiting formation of adipocytes; for treatment of obesity, diabetes, hyperinsulinemia, and polycystic ovary syndrome |
| 03/31/2005 | US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder |
| 03/31/2005 | US20050070530 Dipeptidyl peptidase inhibitors |
| 03/31/2005 | US20050070508 Modulators of receptor kinases such as VEGFR; treating cancer, benign hyperplasia; 6-[2-(1-Methyl-1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-naphthalene-1-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for example |
| 03/31/2005 | US20050070485 Phenylalanine derivatives |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2539159A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | CA2538756A1 Polymorphic forms of a known antihyperlipemic agent |
| 03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/30/2005 | EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay |
| 03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
| 03/30/2005 | EP1518854A1 Substituted 06- benzylguanines and 7- or 9- substituted 8-aza-06-benzylguanines |
| 03/30/2005 | EP1517905A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 03/30/2005 | EP1444197B1 Novel phenyl-propargylether derivatives |
| 03/30/2005 | EP1242089B1 Use of adatanserin for the treatment of acute neurodegenerative disorders |
| 03/30/2005 | EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 03/30/2005 | EP1105378B1 Quinazoline derivatives |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 03/30/2005 | CN1602195A Quinazoline derivatives for the treatment of abnormal cell growth |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872824 Pyrimidine spirobifluorene oligomer for organic light-emitting device |
| 03/29/2005 | US6872740 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase |
| 03/29/2005 | US6872729 Agricultural/ horticultural fungicides containing said derivatives as the active ingredients. |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872727 Polycyclic pyrimidine -2,4(1H,3H)-diones with functionalized alkyl residues at the 1- and/or 3-position(s); methods for their synthesis and pharmaceutical preparation |
| 03/29/2005 | US6872726 Fluorinated di-aryl urea compounds |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/29/2005 | US6872245 Azo pigments |
| 03/29/2005 | CA2176042C Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors |